Healthy individuals have Goodpasture autoantigen-reactive T cells

Juan Zou, Sigrid Hannier, Lindsay S. Cairns, Robert N. Barker, Andrew J. Rees, A. Neil Turner, Richard G. Phelps

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Autoreactive T cells in patients with Goodpasture's disease are specific for epitopes in the Goodpasture antigen (the NC1 domain of the alpha 3 chain of type IV collagen) that are rapidly destroyed during antigen processing to a degree that diminishes their presentation to T cells. We hypothesized that patients' autoreactive T cells exist because antigen processing prevents presentation of the self-epitopes they recognize, circumventing specific tolerance mechanisms. We predicted that autoreactive T cells specific for these peptides should also exist in healthy individuals, albeit at low frequency and in an unprimed state. We obtained blood from healthy unrelated donors and, using a panel of 45 alpha 3(IV)NC1 peptides, identified alpha 3(IV)NC1-specific T cells in all donors. Thirty-six of 45 peptides elicited a proliferative T cell response from at least one subject, and 6 of the peptides evoked a response in >50% of the individuals. This consistency was not caused by selectivity of HLA class II molecules because the donors expressed a diversity of HLA antigens, but was largely a result of the substrate-specificity of the endosomal proteases Cathepsin D and E. There was a significant correlation between high susceptibility to Cathepsin D digestion and the capacity to stimulate primary T cell responses (P = 0.00006). In summary, healthy individuals have low frequencies of unstimulated alpha 3(IV)NC1-reactive T cells with similar specificities to the autoreactive T cells found in patients with Goodpasture disease. In both cases, existence of the alpha 3(IV)NC1-reactive T cells can be accounted for by destructive processing.
Original languageEnglish
Pages (from-to)396-404
Number of pages9
JournalJournal of the American Society of Nephrology
Volume19
Issue number2
Early online date23 Jan 2008
DOIs
Publication statusPublished - Feb 2008

Fingerprint

Autoantigens
T-Lymphocytes
Cathepsin D
Peptides
Antigen Presentation
Epitopes
Cathepsin E
Tissue Donors
Unrelated Donors
Collagen Type IV
HLA Antigens
Substrate Specificity
Digestion
Peptide Hydrolases

Keywords

  • antigen presentation
  • epitope immunodominance
  • rhesus polypeptides
  • cathepsin-D
  • in-vitro
  • specificity
  • identification
  • disease
  • protein
  • site

Cite this

Zou, J., Hannier, S., Cairns, L. S., Barker, R. N., Rees, A. J., Turner, A. N., & Phelps, R. G. (2008). Healthy individuals have Goodpasture autoantigen-reactive T cells. Journal of the American Society of Nephrology, 19(2), 396-404. https://doi.org/10.1681/ASN.2007050546

Healthy individuals have Goodpasture autoantigen-reactive T cells. / Zou, Juan; Hannier, Sigrid; Cairns, Lindsay S.; Barker, Robert N.; Rees, Andrew J.; Turner, A. Neil; Phelps, Richard G.

In: Journal of the American Society of Nephrology, Vol. 19, No. 2, 02.2008, p. 396-404.

Research output: Contribution to journalArticle

Zou, J, Hannier, S, Cairns, LS, Barker, RN, Rees, AJ, Turner, AN & Phelps, RG 2008, 'Healthy individuals have Goodpasture autoantigen-reactive T cells', Journal of the American Society of Nephrology, vol. 19, no. 2, pp. 396-404. https://doi.org/10.1681/ASN.2007050546
Zou, Juan ; Hannier, Sigrid ; Cairns, Lindsay S. ; Barker, Robert N. ; Rees, Andrew J. ; Turner, A. Neil ; Phelps, Richard G. / Healthy individuals have Goodpasture autoantigen-reactive T cells. In: Journal of the American Society of Nephrology. 2008 ; Vol. 19, No. 2. pp. 396-404.
@article{2a7e56bcff514517819c4381a66bb77e,
title = "Healthy individuals have Goodpasture autoantigen-reactive T cells",
abstract = "Autoreactive T cells in patients with Goodpasture's disease are specific for epitopes in the Goodpasture antigen (the NC1 domain of the alpha 3 chain of type IV collagen) that are rapidly destroyed during antigen processing to a degree that diminishes their presentation to T cells. We hypothesized that patients' autoreactive T cells exist because antigen processing prevents presentation of the self-epitopes they recognize, circumventing specific tolerance mechanisms. We predicted that autoreactive T cells specific for these peptides should also exist in healthy individuals, albeit at low frequency and in an unprimed state. We obtained blood from healthy unrelated donors and, using a panel of 45 alpha 3(IV)NC1 peptides, identified alpha 3(IV)NC1-specific T cells in all donors. Thirty-six of 45 peptides elicited a proliferative T cell response from at least one subject, and 6 of the peptides evoked a response in >50{\%} of the individuals. This consistency was not caused by selectivity of HLA class II molecules because the donors expressed a diversity of HLA antigens, but was largely a result of the substrate-specificity of the endosomal proteases Cathepsin D and E. There was a significant correlation between high susceptibility to Cathepsin D digestion and the capacity to stimulate primary T cell responses (P = 0.00006). In summary, healthy individuals have low frequencies of unstimulated alpha 3(IV)NC1-reactive T cells with similar specificities to the autoreactive T cells found in patients with Goodpasture disease. In both cases, existence of the alpha 3(IV)NC1-reactive T cells can be accounted for by destructive processing.",
keywords = "antigen presentation, epitope immunodominance, rhesus polypeptides, cathepsin-D, in-vitro, specificity, identification, disease, protein, site",
author = "Juan Zou and Sigrid Hannier and Cairns, {Lindsay S.} and Barker, {Robert N.} and Rees, {Andrew J.} and Turner, {A. Neil} and Phelps, {Richard G.}",
year = "2008",
month = "2",
doi = "10.1681/ASN.2007050546",
language = "English",
volume = "19",
pages = "396--404",
journal = "Journal of the American Society of Nephrology",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "2",

}

TY - JOUR

T1 - Healthy individuals have Goodpasture autoantigen-reactive T cells

AU - Zou, Juan

AU - Hannier, Sigrid

AU - Cairns, Lindsay S.

AU - Barker, Robert N.

AU - Rees, Andrew J.

AU - Turner, A. Neil

AU - Phelps, Richard G.

PY - 2008/2

Y1 - 2008/2

N2 - Autoreactive T cells in patients with Goodpasture's disease are specific for epitopes in the Goodpasture antigen (the NC1 domain of the alpha 3 chain of type IV collagen) that are rapidly destroyed during antigen processing to a degree that diminishes their presentation to T cells. We hypothesized that patients' autoreactive T cells exist because antigen processing prevents presentation of the self-epitopes they recognize, circumventing specific tolerance mechanisms. We predicted that autoreactive T cells specific for these peptides should also exist in healthy individuals, albeit at low frequency and in an unprimed state. We obtained blood from healthy unrelated donors and, using a panel of 45 alpha 3(IV)NC1 peptides, identified alpha 3(IV)NC1-specific T cells in all donors. Thirty-six of 45 peptides elicited a proliferative T cell response from at least one subject, and 6 of the peptides evoked a response in >50% of the individuals. This consistency was not caused by selectivity of HLA class II molecules because the donors expressed a diversity of HLA antigens, but was largely a result of the substrate-specificity of the endosomal proteases Cathepsin D and E. There was a significant correlation between high susceptibility to Cathepsin D digestion and the capacity to stimulate primary T cell responses (P = 0.00006). In summary, healthy individuals have low frequencies of unstimulated alpha 3(IV)NC1-reactive T cells with similar specificities to the autoreactive T cells found in patients with Goodpasture disease. In both cases, existence of the alpha 3(IV)NC1-reactive T cells can be accounted for by destructive processing.

AB - Autoreactive T cells in patients with Goodpasture's disease are specific for epitopes in the Goodpasture antigen (the NC1 domain of the alpha 3 chain of type IV collagen) that are rapidly destroyed during antigen processing to a degree that diminishes their presentation to T cells. We hypothesized that patients' autoreactive T cells exist because antigen processing prevents presentation of the self-epitopes they recognize, circumventing specific tolerance mechanisms. We predicted that autoreactive T cells specific for these peptides should also exist in healthy individuals, albeit at low frequency and in an unprimed state. We obtained blood from healthy unrelated donors and, using a panel of 45 alpha 3(IV)NC1 peptides, identified alpha 3(IV)NC1-specific T cells in all donors. Thirty-six of 45 peptides elicited a proliferative T cell response from at least one subject, and 6 of the peptides evoked a response in >50% of the individuals. This consistency was not caused by selectivity of HLA class II molecules because the donors expressed a diversity of HLA antigens, but was largely a result of the substrate-specificity of the endosomal proteases Cathepsin D and E. There was a significant correlation between high susceptibility to Cathepsin D digestion and the capacity to stimulate primary T cell responses (P = 0.00006). In summary, healthy individuals have low frequencies of unstimulated alpha 3(IV)NC1-reactive T cells with similar specificities to the autoreactive T cells found in patients with Goodpasture disease. In both cases, existence of the alpha 3(IV)NC1-reactive T cells can be accounted for by destructive processing.

KW - antigen presentation

KW - epitope immunodominance

KW - rhesus polypeptides

KW - cathepsin-D

KW - in-vitro

KW - specificity

KW - identification

KW - disease

KW - protein

KW - site

U2 - 10.1681/ASN.2007050546

DO - 10.1681/ASN.2007050546

M3 - Article

VL - 19

SP - 396

EP - 404

JO - Journal of the American Society of Nephrology

JF - Journal of the American Society of Nephrology

SN - 1046-6673

IS - 2

ER -